Assessment of Cognitive Functioning with the WAIS-III and WMS-III

Tulsky, David S.; Ivnik, Robert J.; Price, Larry R.; Wilkins, C. A.

doi:10.1016/b978-012703570-3/50009-2

Cited by 31 publications

(49 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Further analyses of data from the WAIS-III/WMS-III standardization sample does not support the original conceptual basis of separate immediate and delayed memory factors and indicates unacceptably low loadings of the Faces subtest onto the VMIs (Price et al, 2002;Tulsky & Price, 2003). Accordingly, Tulsky, Ivnik, Price, and Wilkins (2003b) recommend the use of composite Auditory and Visual Memory Indexes, which include both the immediate and delayed tasks. They also recommend replacing Faces with Visual Reproduction to compute the VMIs.…”

Section: Introductionmentioning

confidence: 92%

“…Findings were reported for the original WMS-III indexes and core subtests, and the indexes by Tulsky et al (2003b). The supplementary subtests were not administered to all participants and thus results are reported for a subgroup of the sample on these measures and the revised Visual Memory Indexes which include Visual Reproduction.…”

Section: Wechsler Memory Scale -Third Edition (Wms-iii; Wechsler 1997a)mentioning

confidence: 99%

“…Bonferroni corrections for multiple comparisons were made on the ANCOVAs both for the WMS-III core subtests as a group (i.e., 10 analyses, p<.005), the WMS-III supplementary subtests as a group (i.e., 8 analyses, p<.006) and the original index scores as a group (i.e., 8 analyses, p<.006). Corrections were also made for the group of revised indexes of Tulsky et al (2003b; i.e., 5 analyses, p<.01). Post-hoc analyses were performed to compare the control group with each of the three TBI groups on the WMS-III outcome measures.…”

Section: Statisticsmentioning

confidence: 99%

“…The present study reports WMS-III findings according to severity of brain injury in a sample obtained from consecutive referrals for medico-legal assessment who had sustained Downloaded by [Kungliga Tekniska Hogskola] (Wechsler, 1997a) and revised index measures (Tulsky et al, 2003b), and for each of the WMS-III subtests. Severe Traumatic Brain Injury (TBI: N = 180).…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

WMS-III Findings in Litigants Following Moderate to Extremely Severe Brain Trauma

Langeluddecke

Lucas

2005

Journal of Clinical and Experimental Neuropsychology

View full text Add to dashboard Cite

Published information pertaining to the clinical utility of the WMS-III in assessing memory impairment in traumatic brain injury (TBI) remains inadequate. WMS-III findings are reported for 180 litigants with post-acute moderate to extremely severe TBI, classified into three groups according to injury severity, and a healthy control group. A significant "dose-response" relationship was found between memory impairment and TBI severity for most of the WMS-III indexes and subtests. Effect sizes were large for the Immediate and General Memory Indexes and medium for the Working Memory Index. In general, TBI had a greater effect on the Visual than Auditory Indexes. Effect sizes were greatest for Family Pictures and least for the auditory recognition and working memory tasks. Group findings indicate the immediate memory tasks to be clinically useful in relation to a severe or extremely severe TBI, but not for less severe trauma. Delayed memory tasks do not provide information additional to that obtained from immediate memory measures. The revised Tulsky indexes are no more sensitive to the effects of TBI than the original ones. Differences between WMS-III memory indexes are unlikely to be of diagnostic utility although memory-intelligence discrepancies may be.

show abstract

Section: Introductionmentioning

confidence: 92%

Section: Wechsler Memory Scale -Third Edition (Wms-iii; Wechsler 1997a)mentioning

confidence: 99%

Section: Statisticsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

WMS-III Findings in Litigants Following Moderate to Extremely Severe Brain Trauma

Langeluddecke

Lucas

2005

Journal of Clinical and Experimental Neuropsychology

View full text Add to dashboard Cite

show abstract

“…Administered on the same schedule were the Center for Epidemiologic Studies Depression scale (CESD-10), 46 the Profile of Mood States (POMS), 47 the State-Trait Anxiety Inventory (STAI), 48 and the letter-digit sequencing task from the Wechsler Adult Intelligence Scale III (WAIS), 49 a measure of immediate working memory. Blood pressure, heart rate, and temperature were also measured.…”

Section: Calabrese Et Al 708mentioning

confidence: 99%

Effects of a Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial

Calabrese

Gregory

Leo

et al. 2008

The Journal of Alternative and Complementary Medicine

224

159

View full text Add to dashboard Cite

Objectives: Study aims were to evaluate effects of Bacopa monnieri whole plant standardized dry extract on cognitive function and affect and its safety and tolerability in healthy elderly study participants. Design: The study was a randomized, double-blind, placebo-controlled clinical trial with a placebo run-in of 6 weeks and a treatment period of 12 weeks. Setting/location: Volunteers were recruited from the community to a clinic in Portland, Oregon by public notification. Subjects: Fifty-four (54) participants, 65 or older (mean 73.5 years), without clinical signs of dementia, were recruited and randomized to Bacopa or placebo. Forty-eight (48) completed the study with 24 in each group. Interventions: Standardized B. monnieri extract 300 mg/day or a similar placebo tablet orally for 12 weeks. Outcome measures: The primary outcome variable was the delayed recall score from the Rey Auditory Verbal Learning Test (AVLT). Other cognitive measures were the Stroop Task assessing the ability to ignore irrelevant information, the Divided Attention Task (DAT), and the Wechsler Adult Intelligence Scale (WAIS) letter-digit test of immediate working memory. Affective measures were the State-Trait Anxiety Inventory, Center for Epidemiologic Studies Depression scale (CESD)-10 depression scale, and the Profile of Mood States. Vital signs were also monitored. Results: Controlling for baseline cognitive deficit using the Blessed Orientation-Memory-Concentration test, Bacopa participants had enhanced AVLT delayed word recall memory scores relative to placebo. Stroop results were similarly significant, with the Bacopa group improving and the placebo group unchanged. CESD-10 depression scores, combined state plus trait anxiety scores, and heart rate decreased over time for the Bacopa group but increased for the placebo group. No effects were found on the DAT, WAIS digit task, mood, or blood pressure. The dose was well tolerated with few adverse events (Bacopa n ϭ 9, placebo n ϭ 10), primarily stomach upset. Conclusions: This study provides further evidence that B. monnieri has potential for safely enhancing cognitive performance in the aging. 707

show abstract

Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder

Martin

Bartolomeo

Howell

et al. 2017

Eur Arch Psychiatry Clin Neurosci

View full text Add to dashboard Cite

Schizophrenia spectrum disorder (SZ) is associated with deficits in auditory perception as well as auditory verbal hallucinations (AVH). However, the relationship between auditory feature perception and auditory verbal hallucinations (AVH), one of the most commonly occurring symptoms in psychosis, has not been well characterized. This study evaluated perception of a broad range of auditory features in SZ and determined whether current AVHs relate to auditory feature perception. Auditory perception, including frequency, intensity, duration, pulse-train and temporal order discrimination, as well as an embedded tone task, was assessed in both AVH (n = 20) and non-AVH (n = 24) SZ individuals and in healthy controls (n = 29) with the Test of Basic Auditory Capabilities (TBAC). The Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ) was used to assess the experience of auditory hallucinations in patients with SZ. Findings suggest that compared to controls, the SZ group had greater deficits on an array of auditory features, with non-AVH SZ individuals showing the most severe degree of abnormality. IQ and measures of cognitive processing were positively associated with performance on the TBAC for all SZ individuals, but not with the HPSVQ scores. These findings indicate that persons with SZ demonstrate impaired auditory perception for a broad range of features. It does not appear that impaired auditory perception is associated with recent auditory verbal hallucinations, but instead associated with the degree of intellectual impairment in SZ.

show abstract

Assessment of Cognitive Functioning with the WAIS-III and WMS-III

Cited by 31 publications

References 32 publications

WMS-III Findings in Litigants Following Moderate to Extremely Severe Brain Trauma

WMS-III Findings in Litigants Following Moderate to Extremely Severe Brain Trauma

Effects of a Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial

Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder

Contact Info

Product

Resources

About